Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Dec 13;10(2):e002506. doi: 10.1136/openhrt-2023-002506

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

PMC Copyright notice

Distribution of baseline treatment by cohort of enrolment in patients eligible for OAC treatment. Blue colours: proportion of patients receiving OAC, green colours: proportion of patients not given OAC treatment. The periods for enrolment were: 2010–2011 (cohort 1), 2011–2013 (cohort 2), 2013–2014 (cohort 3), 2014–2015 (cohort 4), 2014–2015 (cohort 4). AP, antiplatelet treatment; NOAC, non-vitamin K oral anticoagulant; OAC, oral anticoagulation; VKA, vitamin K antagonist treatment.